• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry

    TEAM Technologies Acquires ViruDefense

    KORU Medical Systems Names New CEO

    Medtronic Receives FDA Approval for Pipeline Flex Embolization Device with Shield Technology

    Johnson & Johnson Vision Unveils Acuvue Abiliti
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Unicep

    Forefront Medical Technology

    Trademark Plastics Inc.

    Medicoil

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    Spectrum Plastics Group

    K-Tube Technologies

    Medbio LLC

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    The Evolution of Chemical Characterization for Medical Devices

    Evaluation of biological safety of devices is experiencing some of the most significant changes in history.

    Related CONTENT
    • Developing Leaders in the Workforce—MPO Videobites
    • Realizing the Value of Today’s Connected Worker—A Medtech Makers Q&A
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • EMS' Engineering Resources Increasingly in Demand
    Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi AppTec Medical Device Testing04.01.21
    In recent years, medical device manufacturers have faced rapidly evolving expectations about conducting biocompatibility testing to support preclinical product safety testing. With the recent changes to ISO 10993, the evaluation of biological safety of devices is experiencing some of the most significant changes in history.

    Regulators quickly adopted the publication of ISO 10993-1:2018 (Part 1) because it requires manufacturers to develop biological test strategies based on their devices' potential risks. With this new guidance, physical and chemical information should be the starting point for identifying device-specific risks.

    Additionally, the number of devices that fall within reach of ISO 10993-1 and corresponding guidance documents has rapidly expanded. Teams still familiarizing themselves with these evaluation processes and regulatory expectations should take the time to understand the history of the methods at hand, the thought process that has advanced it, and how to apply this historical lens moving forward.

    The Debut of Chemical Characterization
    Manufacturers became accustomed to conducting a more standardized set of tests based on their device's contact type and duration before the revised ISO 10993-1 was released in 2018. Testing strategies specific to the device were not common, and oftentimes, the testing that could reveal unknown risks, such as the chemical characterization and risk assessment, was the final task left before product approval submission. This approach could, at times, leave manufacturers scrambling at the last moment to mitigate unanticipated risks.

    During this period of time, the shift to identifying potentially harmful compounds earlier in the process was gaining traction with regulatory bodies. With the pathway to submission leaving little room for error, this new mindset often left sponsors with concerns they may not have planned to address.

    The U.S. Food and Drug Administration (FDA) created a launchpad for revising the standard through its 2016 Draft Guidance on the Use of ISO 10993 Part 1. The guidance outlined the role of chemical characterization in the process and the importance of addressing it first. This FDA guidance played an instrumental role in revising ISO 10993-1, which formalized chemical characterization and the subsequent risk assessment as a fundamental requirement in assessing a device's safety.

    Chemical characterization can take many forms, from a paper-based review of all materials to a targeted study focusing on one compound of concern. Most frequently, it requires an extractables study consisting of exaggerated extraction of the device, followed by an analysis of the chemical constituents using a range of analytical methods.

    In the early days, high-risk devices were typically the products that required chemical characterization. Slowly, chemistry became a requirement for other devices, including permanent implants, prolonged contacting devices, and devices in contact with circulating blood.

    The revised version of ISO 10993-1 was released in 2018 and created a new standard that prioritized chemical characterization in evaluating a medical device's biological safety. This standard continued to drive the shift in regulatory expectations and the changing approach to determining biocompatibility endpoints. As reviewers became savvier from a technical standpoint, they began to ask more questions and required manufacturers justify their scientific approach to chemical characterization.

    The Evolution of Testing Methods
    As testing evolved, regulators supported the refinement of acceptable testing plans to include chemical characterization. These analytically selective and sensitive methods began to prove their value as the industry shifted from a checklist approach to a more strategic method of biological safety testing. Over time, the requirements for conducting chemistry testing have improved and become more rigorous.

    One example of the evolving testing requirements is how the number of solvents applied by laboratories has increased in addition to the aggressiveness of the extractions themselves. The pendulum continued to swing, applying exhaustive extraction techniques to both prolonged and permanent devices. This change pushed a growing portion of the market to new lengths, which led to extended testing timelines and increasing costs.

    Identifying the compounds detected in chemical characterization studies was no longer nice-to-have information but mandatory for the risk assessment process. A more robust understanding of chemicals present allowed for improved risk assessments. Effectively interpreting this data often requires a collaborative team that is in tune with how each regulatory body interprets the guidance at the given moment.

    The publication of ISO 10993-18:2020 introduces the analytical evaluation threshold (AET), which is the conversion from a dose-based threshold used by toxicologists to a concentration-based threshold used by chemists. The AET requires a partnership between the chemist and the toxicologist who will perform the risk assessment. Together they use inputs including the frequency and duration of the medical device’s clinical use, the extraction information used in the laboratory, and the uncertainty of the analytical method(s) to determine a level for which compounds detected in the chemistry study need to be identified. Not only does it create a “common language” between two integral parts of the evaluation process, but it levels the playing field of what manufacturers should expect from their laboratory testing partners.

    Regulators are gradually implementing enhanced material identification expectations across the board and driving the importance of advanced chemical characterization. This is evident by the release of the FDA guidance, Use of International Standard ISO 10993-1, “Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process.” Manufacturers must be on their toes to keep up and consistently assess their compliance with the latest requirements.

    Continued Evolution, Continued Investments
    In a perpetual effort to better understand the chemical risks of devices entering the market, the industry continues to establish more consistent and thorough evaluation procedures that better recognize the risks associated with each device.

    The different chemical characterization methods are ever-evolving, and regulators expect more information from these studies, including a justification of the approach (i.e., choice of solvents, analytical method, and extraction conditions). To keep up with this process, manufacturers should maintain current records that include regulators' current expectations. Legacy products and those with testing procedures dated from even just a few years ago may have a lot of catching up to do.

    For many products, testing completed before the release of ISO 10993-18:2020 is likely obsolete with the current chemical characterization studies' expectations. Managing a range of products in this environment can be an arduous process during the transition, but the efforts will benefit patients in the long run.

    Looking Forward
    The medical device industry is always working toward ensuring patient safety remains the top priority, and the methods for supporting safety through testing will continue to evolve. Manufacturers should understand the latest requirements and be prepared to invest in a quality chemical characterization study to ensure a solid foundation for the rest of their program. In fact, in the next year or so, an updated ISO 10993-17 guidance document will provide manufacturers additional information on performing toxicological risk assessments of these chemical constituents.

    Medical device companies are responsible for evaluating their product’s safety before entering the market, but it is not a challenge they should face alone. Leaning on industry partners involved in the regulatory landscape can help companies stay relevant and competitive by maintaining the most up-to-date technical files. More information on regulatory expectations and some additional tips on preparing for regulatory requests and minimizing impact can be found at bit.ly/3qRiTFD. 


    Sandi Schaible is the senior director of analytical chemistry and regulatory toxicology at St. Paul, Minn.-based WuXi AppTec Medical Device Testing, which specializes in extractables and leachables studies. She is a U.S. delegate and international delegate for ISO 10993 part 18 in chemical characterization, and also a U.S. delegate for ISO 10993 part 13 and the particulates committee (TIR42).
    Related Searches
    • Testing
    Related Knowledge Center
    • Testing
    Suggested For You
    How Can a Device End User Aid in Cybersecurity? How Can a Device End User Aid in Cybersecurity?
    What Could Medical Device Hacking’s Future Look Like? What Could Medical Device Hacking’s Future Look Like?
    Developing Leaders in the Workforce—MPO Videobites Developing Leaders in the Workforce—MPO Videobites
    Realizing the Value of Today’s Connected Worker—A Medtech Makers Q&A Realizing the Value of Today’s Connected Worker—A Medtech Makers Q&A
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors Gynesonics Appoints Susan Stimson to Its Board of Directors
    EMS EMS' Engineering Resources Increasingly in Demand
    FDA OKs Canon Medical FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    Real-World Medical Device Hacking Tales Real-World Medical Device Hacking Tales
    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Acutus Medical Receives FDA Clearance of AcQCross Acutus Medical Receives FDA Clearance of AcQCross
    Portable Medical Devices Market to Reach $100 Billion by 2027 Portable Medical Devices Market to Reach $100 Billion by 2027

    Related Columns

    • Testing
      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Going Beyond the Regulations to Evaluate Relevant Medical Device Risk

      Companies need to review their testing plan so it supports a successful submission, saves time, and ensures the long-term success of their product.
      Sherry Parker, Ph.D., Senior Director of Regulatory Toxicology, WuXi AppTec Medical Device Testing 06.04.20

    • Testing
      The Importance of Usability/Human Factors Testing

      The Importance of Usability/Human Factors Testing

      When is the work of human factors over, and how does your team know they are prepared for summative testing?
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.20

    • Materials | Testing
      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      Particle Particulars: Why this Analysis Is Foundational for Successful Devices

      In the mid-2000s, medical device experts were hopeful they’d found one solution to longer-lasting implants.
      Dawn A. Lissy, President & Founder, Empirical 03.04.20


    • R&D & Design | Testing
      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      FDA Guidelines for Employing X-ray Inspection in Medical Device Development

      Different materials exhibit different radiopacity as a function of material composition (i.e. atomic weight) and thickness.
      Gil Zweig, President, Glenbrook Technologies 01.29.20

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19


    • Testing
      Why Big Companies With Internal Labs Should Outsource Testing

      Why Big Companies With Internal Labs Should Outsource Testing

      ...
      Dawn A. Lissy, President & Founder, Empirical 03.07.19

    • Packaging & Sterilization | Testing
      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      Coming Clean: Developing Standards for Cleaning Reusable Devices and Instruments

      ...
      Dawn A. Lissy, President & Founder, Empirical 07.26.18

    • 3D/Additive Manufacturing | Testing
      The Final Four: My Top Headlines for 2017

      The Final Four: My Top Headlines for 2017

      ...
      Dawn A. Lissy, President & Founder, Empirical 11.07.17


    • Packaging & Sterilization | Testing
      Packaging Validations—Looking Beyond ISO 11607

      Packaging Validations—Looking Beyond ISO 11607

      ...
      Christopher Scott, Vice President, Eurofins Medical Device Testing 10.05.17

    • Testing
      So We’re All on the Same Page: You Need a Test Plan

      So We’re All on the Same Page: You Need a Test Plan

      ...
      Dawn A. Lissy, Empirical 09.01.17

    • 3D/Additive Manufacturing | R&D & Design | Testing
      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      Pro Tips for Prototypes: The Smart Way to Manage Device Iterations

      ...
      Dawn A. Lissy, Empirical 07.26.17


    • Digital Health | Software & IT | Testing
      Recent Cyber Attack Enough to Make Medtech WannaCry

      Recent Cyber Attack Enough to Make Medtech WannaCry

      ...
      Michael Barbella, Managing Editor 06.06.17

    • R&D & Design | Testing
      The Human Factor

      The Human Factor

      ...
      Steve Maylish and Dave Hines, Fusion Biotec 05.01.17

    • Testing
      Peruvian Prospects:  The Medical Device Industry of a Country Founded on Precious Metals

      Peruvian Prospects: The Medical Device Industry of a Country Founded on Precious Metals

      ...
      Dawn A. Lissy, President & Founder, Empirical 04.03.17


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • J&J’s Veritas Vision System Receives FDA Clearance And CE Mark
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    • TEAM Technologies Acquires ViruDefense
    • KORU Medical Systems Names New CEO
    • Medtronic Receives FDA Approval for Pipeline Flex Embolization Device with Shield Technology
    • Johnson & Johnson Vision Unveils Acuvue Abiliti
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Announces Installation of Agile Filling System at Bethlehem, PA Facility
    PepsiCo and Ingredion Begin Pilot Partnership with Soil and Water Outcomes Fund
    Innova Market Insights: Sports Nutrition Must Focus on Flavors for Mainstream Consumers
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Shareholders Approve Final Dividend at Annual General Meeting
    Sustainable Plastics Will Make Up More Than 15% of Production by 2030
    Axalta Coating Systems Announces $625 Million Increase to Share Repurchase Program Authorization
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Study Shows Benefits of CCHD Screening Using Masimo SET Pulse Oximetry
    TEAM Technologies Acquires ViruDefense
    KORU Medical Systems Names New CEO
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data
    Syneos, Medable Partner for New Decentralized Capabilities
    CSafe Global Appoints SVP of Technology and Innovation
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    New Non-Profit Collaborative Aims to Reduce Cosmetic Packaging Waste
    WWP Beauty Marks Earth Day with New Sustainable Packaging Collections
    How Do Americans Feel About Diversity in Beauty Advertising?
    Happi

    Latest Breaking News From Happi

    JAWS Launches New Multi-Purpose Cleaner
    Kao Launches Oribe in Japan
    Love Beauty and Planet Shares Sustainability Initiatives With Refillable Hair Care at Target
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    SE-DA Invests in Kornit Presto S
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Epson upgrades SurePress demo facility
    Xeikon helps converters navigate toner and inkjet
    Mactac introduces Simply Sustainable initiative
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Savaré Strengthens Technical Support for the Americas
    FiberVisions, Avgol Partner with Polymateria
    High-Tech Conversions Launches Wipes Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears Orthofix's 3D-Printed FORZA Titanium TLIF Spacer System
    Patients Conclude Clinical Visits in Knee Osteoarthritis Treatment Study
    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    SEMI Applauds Introduction of Endless Frontier Act
    TechBlick Announces Agenda For Next Printed, Hybrid, Structural, 3D Electronics Virtual Event

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login